article_metadata: Xiaoqian Song Jingjiao Chen Chenyang Jin Yilong Peng Yuewen Sun Xueping Zheng
article_metadata: 10.3389/fimmu.2024.1528989
article_metadata: Front Immunol
article_metadata: 2025 Jan 13:15:1528989.
article_metadata: anti-aqp4 antibodies anti-acetylcholine receptors antibodies inebilizumab myasthenia gravis neuromyelitis optica spectrum disorder
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/39872531/
article_metadata: Antibodies, Monoclonal, Humanized / adverse effects Antibodies, Monoclonal, Humanized / therapeutic use Aquaporin 4 / immunology Autoantibodies / blood Autoantibodies / immunology Myasthenia Gravis / diagnosis Myasthenia Gravis / drug therapy Myasthenia Gravis / immunology Neuromyelitis Optica / drug therapy Neuromyelitis Optica / immunology
article_metadata: Antibodies, Monoclonal, Humanized / adverse effects Antibodies, Monoclonal, Humanized / therapeutic use Aquaporin 4 / immunology Autoantibodies / blood Autoantibodies / immunology Myasthenia Gravis / diagnosis Myasthenia Gravis / drug therapy Myasthenia Gravis / immunology Neuromyelitis Optica / drug therapy Neuromyelitis Optica / immunology Case Reports Review Female Humans Immunoglobulin G / blood Middle Aged Treatment Outcome Aquaporin 4 Antibodies, Monoclonal, Humanized Autoantibodies inebilizumab Immunoglobulin G AQP4 protein, human
article_metadata: PMC11769772
article_metadata: 39872531
article_metadata: Inebilizumab treatment in a patient with co-occurring AQP4-IgG positive neuromyelitis optica spectrum disorder and myasthenia gravis: a case report and literature review
article_metadata: 2025